EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PDK4 and nutrient responses explain muscle specific manifestation in mitochondrial disease

Swagat Pradhan iD, Takayuki Mito, Nahid A Khan, Sofiia Olander, Aleksandra Zhaivoron, Thomas G McWilliams, Anu Suomalainen

Clinical and Translational Medicine · 2025-07 · 15 (7)

DOI: 10.1002/ctm2.70404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 18.07.2025. Verfasst von Swagat Pradhan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Pyruvate Dehydrogenase Acetyl-Transferring Kinase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland, Doctoral Programme in Integrative Life Sciences of University of Helsinki, Doctoral Programme in Brain and Mind of University of Helsinki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitochondria elicit various metabolic stress responses, the roles of which in diseases are poorly understood. Here, we explore how different muscles of one individual—extraocular muscles (EOMs) and quadriceps femoris (QFs) muscles—respond to mitochondrial disease. The aim is to explain why EOMs atrophy early in the disease, unlike other muscles.

Methods

We used a mouse model for mitochondrial myopathy (“deletor”), which manifests progressive respiratory chain deficiency and human disease hallmarks in itsmuscles. Analyses included histology, ultrastructure, bulk and single‐nuclear RNA‐sequencing, metabolomics, and mitochondrial turnover assessed through in vivo mitophagy using transgenic mito‐QC marker mice crossed to deletors.

Results

In mitochondrial muscle disease, large QFs upregulate glucose uptake that drives anabolic glycolytic one‐carbon metabolism and mitochondrial integrated stress response. EOMs, however, react in an opposite manner, inhibiting glucose and pyruvate oxidation by activating PDK4, a pyruvate dehydrogenase kinase and inhibitor. Instead, EOMs upregulate acetyl‐CoA synthesis and fatty‐acid oxidation pathways, and accumulate lipids. In QFs, Pdk4 transcription is not induced.‐ Amino acid levels are increased in QFs but are low in EOMs suggesting their catabolic use for energy metabolism. Mitophagy is stalled in both muscle types, in the most affected fibers.

Conclusions

Our evidence indicates that different muscles respond differently to mitochondrial disease even in one individual. While large muscles switch to anabolic mode and glycolysis, EOMs actively inhibit glucose usage. They upregulate lipid oxidation pathway, a non‐optimal fuel choice in mitochondrial myopathy, leading to lipid accumulation and possibly increased reliance on amino acid oxidation. We propose that these consequences of non‐optimal nutrient responses lead to EOMatrophy and progressive external ophthalmoplegia in patients. Our evidence highlights the importance of PDK4 and aberrant nutrient signaling underlying muscle atrophies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitochondrial DiseasesPyruvate Dehydrogenase Acetyl-Transferring KinaseAnimalsMiceDisease Models, AnimalMuscle, SkeletalHumans

Stichwörter der Autor:innen

integrated stress responsemitochondrial diseasemitochondrial myopathynutrient signalingprogressive external ophthalmoplegiapyruvate dehydrogenase kinase

Substanzen

Pdk4 protein, mousePyruvate Dehydrogenase Acetyl-Transferring Kinase

Autor:innen und Institutionen

  • Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Department of Cellular Physiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • HiLife, University of Helsinki, Helsinki, Finland.
  • Department of Anatomy, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • HUS Diagnostic Centre, Helsinki University Hospital, Helsinki, Finland.

ORCID-Profile: Swagat Pradhan

Förderung

  • Research Council of Finland
  • Doctoral Programme in Integrative Life Sciences of University of Helsinki
  • Doctoral Programme in Brain and Mind of University of Helsinki
  • Päivikki ja Sakari Sohlbergin Säätiö
  • Sigrid Juséliuksen Säätiö
  • Novo Nordisk Fonden
  • Helsingin Yliopisto
  • Jane and Aatos Erkko Foundation

Zitieren

APA

Pradhan, S., Mito, T., Khan, N. A., Olander, S., Zhaivoron, A., McWilliams, T. G., & Suomalainen, A. (2025). PDK4 and nutrient responses explain muscle specific manifestation in mitochondrial disease. Clinical and Translational Medicine, 15(7). https://doi.org/10.1002/ctm2.70404

Vancouver

Pradhan S, Mito T, Khan NA, Olander S, Zhaivoron A, McWilliams TG, et al. PDK4 and nutrient responses explain muscle specific manifestation in mitochondrial disease. Clinical and Translational Medicine. 2025;15(7). doi:10.1002/ctm2.70404

BibTeX
@article{Pradhan2025,
  author = {Pradhan, Swagat and Mito, Takayuki and Khan, Nahid A and Olander, Sofiia and Zhaivoron, Aleksandra and McWilliams, Thomas G and Suomalainen, Anu},
  title = {PDK4 and nutrient responses explain muscle specific manifestation in mitochondrial disease},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  volume = {15},
  number = {7},
  doi = {10.1002/ctm2.70404}
}
Kostenlos starten →